Sign in

NCT04628026RecruitingPhase 3

Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

A Randomized, Placebo-Controlled Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2

Source: ClinicalTrials.gov · Last updated 3 Nov 2026

Brief summary (registry, in English)

A Randomized, Placebo-Controlled Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2

Status (registry)
Recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
650 (estimated)
First submitted
3 Nov 2020
Start date
13 Sept 2022
Primary completion date
Mar 2029
Lead sponsor
University of Ulm
NCT number
NCT04628026
EU CT number
2023-507518-28-00
EudraCT number
2020-004453-71

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 650
  • From 13 Sept 2022 to the primary completion date, Mar 2029
  • 87 sites in 8 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Patients with newly diagnosed acute myeloid leukemia (AML) according to the International Consensus Classification (ICC).
  • Age ≥ 18 and ≤ 75 years.
  • Patients considered eligible for intensive chemotherapy.
  • Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2.
  • Molecular analysis centrally performed in AMLSG and HOVON laboratories.
  • Adequate renal function as evidenced by serum creatinine ≤ 2.0 × upper limit of norm (ULN) or creatinine clearance \>40 mL/min based on the Cockcroft-Gault glomerular filtration rate (GFR).
  • Adequate hepatic function as evidenced by:
    • Serum total bilirubin ≤ 2.5 × ULN unless considered due to Gilbert's disease, or leukemic involvement following approval by the Principal Investigators or Trial Coordinators of the study
    • Aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) ≤ 3.0 × ULN, unless considered due to leukemic involvement following approval by the Principal Investigators or Trial Coordinators.
  • No prior chemotherapy for AML, except hydroxyurea for up to 14 days during the diagnostic screening phase for the control of peripheral leukemic blasts in patients with leukocytosis (e.g., white blood cell \[WBC\] counts \> 25x109/L); patients may have had previous treatment with erythroid stimulating agents (ESA) or hypomethylating agents (HMAs) for an antecedent phase of MDS; ESA and HMAs have to be stopped at least four weeks before start of study treatment.
  • Patients must not have received a known strong or moderate CYP3A inducer 7 days before start of study treatment. Patients must have no known medical conditions requiring chronic therapy with moderate or strong CYP3A inducers.
  • Female patient must either:
    • Be of nonchildbearing potential:
    • Postmenopausal (defined as at least 1 year without any menses)
    • Documented surgically sterile (e.g. documented hysterectomy, bilateral oophorectomy, bilateral salpingectomy or congenital sterile) or status post hysterectomy (at least 1 month prior to screening)
    • Or, if of childbearing potential (not surgically sterile and not postmenopausal)
    • Not planning to become pregnant during the study and for 6 months after the final study drug administration
    • And have a negative urine or serum pregnancy test at screening
    • And, if heterosexually active, agree to consistently apply one highly effective\* method of birth control in combination to a barrier method for the duration of the study and for 27 weeks after the final study drug administration
    • \*Highly effective forms of birth control include
    • Consistent and correct usage of established hormonal contraceptives that inhibit ovulation for at least 1 month prior to taking study drug. (hormonal contraception is only a highly effective method of birth control, if a combined \[estrogen and progestogen containing\] hormonal contraception or a progestogen-only hormonal contraception - both associated with inhibition of ovulation - is used.
    • Established intrauterine device (IUD) or intrauterine system (IUS)
    • Bilateral tubal occlusion
    • Vasectomy - a vasectomy is highly effective contraception method provided the absence of sperm has been confirmed. If not, an additional highly effective method of contraception should be used.
    • Male is sterile due to a bilateral orchiectomy.
    • Sexual abstinence is considered a highly effective method only if defined as refraining from heterosexual activity during the entire period of risk associated with the study drug. The reliability of sexual abstinence needs to be evaluated in relation to the duration of the clinical study and the preferred and usual lifestyle of the patient.
    • \*List is not all inclusive. Prior to enrolment, the investigator is responsible for confirming patient will utilize highly effective forms of birth control in combination with a barrier method according to locally accepted standards during the protocol defined period.
    • Female patient must agree not to breastfeed starting at screening and throughout the study period, and for 2 months and 1 week after the final study drug administration.
    • Female patient must not donate ova starting at screening and throughout the study period, and for 27 weeks after the final study drug administration.
  • Men must use a latex condom during any sexual contact with WOCBP, even if they have undergone a successful vasectomy and must agree to avoid to father a child (while on therapy and for 27 weeks after the final study drug administration). In addition, their female partners of childbearing potential have to use a highly effective method of birth control.
  • Male patient must not donate sperm starting at screening and throughout the study period and for 27 weeks after the final study drug administration.
  • Able to understand and willing to sign an informed consent form (ICF).

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (87)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tirol Kliniken GmbH
Coordinator of this site? Confirm its status
InnsbruckAustriaRecruiting
Ordensklinikum Linz GmbH
Coordinator of this site? Confirm its status
LinzAustriaRecruiting
Kepler Universitaetsklinikum GmbH
Coordinator of this site? Confirm its status
LinzAustriaRecruiting
Landeskrankenhaus (LKH) Rankweil, Interne E am Landeskrankenhaus Rankweil
Coordinator of this site? Confirm its status
RankweilAustriaRecruiting
Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH
Coordinator of this site? Confirm its status
SalzburgAustriaRecruiting
Hanusch Krankenhaus der Wiener Gebietskrankenkasse
Coordinator of this site? Confirm its status
ViennaAustriaRecruiting
Ziekenhuis Aan De Stroom
Coordinator of this site? Confirm its status
AntwerpBelgiumRecruiting
Az St-Jan Brugge-Oostende A.V.
Coordinator of this site? Confirm its status
BruggeBelgiumRecruiting
Universitair Ziekenhuis Brussel
Coordinator of this site? Confirm its status
BrusselBelgiumRecruiting
Katholieke Universiteit te Leuven
Coordinator of this site? Confirm its status
LeuvenBelgiumRecruiting
Algemeen Ziekenhuis Delta
Coordinator of this site? Confirm its status
RoeselareBelgiumRecruiting
CHU UCL NAMUR - Mont Godinne
Coordinator of this site? Confirm its status
YvoirBelgiumRecruiting
Klinikum Hochsauerland GmbH
Coordinator of this site? Confirm its status
ArnsbergGermanyRecruiting
Klinikum Aschaffenburg-Alzenau gGmbH
Coordinator of this site? Confirm its status
AschaffenburgGermanyRecruiting
HELIOS Klinikum Bad Saarow GmbH
Coordinator of this site? Confirm its status
Bad SaarowGermanyRecruiting
Charite Universitaetsmedizin Berlin KöR
Coordinator of this site? Confirm its status
BerlinGermanyRecruiting
Vivantes Netzwerk fuer Gesundheit GmbH
Coordinator of this site? Confirm its status
BerlinGermanyRecruiting
Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH
Coordinator of this site? Confirm its status
BochumGermanyRecruiting
Universitaetsklinikum Bonn AöR
Coordinator of this site? Confirm its status
BonnGermanyRecruiting
Gesundheit Nord gGmbH Klinikverbund Bremen
Coordinator of this site? Confirm its status
BremenGermanyRecruiting
Staedtisches Klinikum Braunschweig gGmbH
Coordinator of this site? Confirm its status
BrunswickGermanyRecruiting
Klinikum Darmstadt GmbH
Coordinator of this site? Confirm its status
DarmstadtGermanyRecruiting
St.-Johannes-Hospital Dortmund
Coordinator of this site? Confirm its status
DortmundGermanyRecruiting
Klinikum Frankfurt Hoechst GmbH
Coordinator of this site? Confirm its status
Frankfurt Am MainGermanyRecruiting
Justus-Liebig-Universitaet Giessen
Coordinator of this site? Confirm its status
GiessenGermanyRecruiting
Wilhelm-Anton-Hospital Goch
Coordinator of this site? Confirm its status
GochGermanyRecruiting
Universitätsmedizin Greifswald
Coordinator of this site? Confirm its status
GreifswaldGermanyRecruiting
Martin-Luther-Universitaet Halle-Wittenberg
Coordinator of this site? Confirm its status
Halle (Saale)GermanyRecruiting
Asklepios Klinik Altona
Coordinator of this site? Confirm its status
HamburgGermanyRecruiting
Asklepios Klinik St George
Coordinator of this site? Confirm its status
HamburgGermanyRecruiting
University Medical Center Hamburg-Eppendorf
Coordinator of this site? Confirm its status
HamburgGermanyRecruiting
Johanniter-Kliniken Hamm GmbH
Coordinator of this site? Confirm its status
HammGermanyRecruiting
KRH Klinikum SILOAH
Coordinator of this site? Confirm its status
HannoverGermanyRecruiting
Medizinische Hochschule Hannover
Coordinator of this site? Confirm its status
HanoverGermanyRecruiting
SLK-Kliniken Heilbronn GmbH
Coordinator of this site? Confirm its status
HeilbronnGermanyRecruiting
Marien Hospital Herne
Coordinator of this site? Confirm its status
HerneGermanyRecruiting
Universitaetsklinikum des Saarlandes AöR
Coordinator of this site? Confirm its status
HomburgGermanyRecruiting
Westpfalz-Klinikum GmbH
Coordinator of this site? Confirm its status
KaiserslauternGermanyRecruiting
Staedtisches Klinikum Karlsruhe gGmbH
Coordinator of this site? Confirm its status
KarlsruheGermanyRecruiting
Universitätsklinikum Schleswig-Holstein
Coordinator of this site? Confirm its status
LübeckGermanyRecruiting
Klinikum der Stadt Ludwigshafen am Rhein gGmbH
Coordinator of this site? Confirm its status
Ludwigshafen Am RheinGermanyRecruiting
Otto Von Guericke Universitaet Magdeburg
Coordinator of this site? Confirm its status
MagdeburgGermanyRecruiting
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
Coordinator of this site? Confirm its status
MainzGermanyRecruiting
Muhlenkreiskliniken AöR
Coordinator of this site? Confirm its status
MindenGermanyRecruiting
Klinikum rechts der Isar der TU Muenchen AöR
Coordinator of this site? Confirm its status
MunichGermanyRecruiting
Ortenau Klinikum
Coordinator of this site? Confirm its status
OffenburgGermanyRecruiting
Klinikum Oldenburg Aor
Coordinator of this site? Confirm its status
OldenburgGermanyRecruiting
Universitaetsklinikum Regensburg AöR
Coordinator of this site? Confirm its status
RegensburgGermanyRecruiting
Rostock University Medical Center
Coordinator of this site? Confirm its status
RostockGermanyRecruiting
Diakonie-Klinikum Stuttgart Diakonissenkrankenhaus Und Paulinenhilfe gGmbH
Coordinator of this site? Confirm its status
StuttgartGermanyRecruiting
Kliniken Suedostbayern AG
Coordinator of this site? Confirm its status
TraunsteinGermanyRecruiting
Klinikum Mutterhaus der Borromaeerinnen gGmbH
Coordinator of this site? Confirm its status
TrierGermanyRecruiting
Barmherzige Brueder Trier gGmbH
Coordinator of this site? Confirm its status
TrierGermanyRecruiting
Universitaetsklinikum Tuebingen AöR
Coordinator of this site? Confirm its status
TuebingenGermanyRecruiting
Universitaetsklinikum Ulm AoR
Coordinator of this site? Confirm its status
UlmGermanyRecruiting
Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH
Coordinator of this site? Confirm its status
Villingen-SchwenningenGermanyRecruiting
Helios Universitaetsklinikum Wuppertal
Coordinator of this site? Confirm its status
WuppertalGermanyRecruiting
North Estonia Medical Centre Foundation
Coordinator of this site? Confirm its status
TallinnEstoniaRecruiting
Tartu University Hospital
Coordinator of this site? Confirm its status
Tartu LinnEstoniaRecruiting
Helsinki University Central Hospital Meilahden Kolmiosairaala
Coordinator of this site? Confirm its status
HelsinkiFinlandRecruiting
Tampere University Hospital
Coordinator of this site? Confirm its status
TampereFinlandRecruiting
Vilnius University Hospital Santaros Klinik
Coordinator of this site? Confirm its status
VilniusLithuaniaNot yet recruiting
Meander Medisch Centrum
Coordinator of this site? Confirm its status
AmersfoortNetherlandsRecruiting
Amsterdam UMC Stichting
Coordinator of this site? Confirm its status
AmsterdamNetherlandsRecruiting
OLVG
Coordinator of this site? Confirm its status
AmsterdamNetherlandsRecruiting
Rijnstate Ziekenhuis Stichting
Coordinator of this site? Confirm its status
ArnhemNetherlandsRecruiting
Amphia Hospital
Coordinator of this site? Confirm its status
BredaNetherlandsRecruiting
Reinier de Graaf Gasthuis
Coordinator of this site? Confirm its status
DelftNetherlandsRecruiting
Jeroen Bosch ziekenhuis
Coordinator of this site? Confirm its status
Den BoschNetherlandsRecruiting
Hagaziekenhuis, locatie Leyweg
Coordinator of this site? Confirm its status
Den HaagNetherlandsRecruiting
Albert Schweitzer Ziekenhuis
Coordinator of this site? Confirm its status
DordrechtNetherlandsRecruiting
Máxima Medisch Centrum
Coordinator of this site? Confirm its status
EindhovenNetherlandsRecruiting
Medisch Spectrum Twente
Coordinator of this site? Confirm its status
EnschedeNetherlandsRecruiting
UMCG
Coordinator of this site? Confirm its status
GroningenNetherlandsRecruiting
Medisch Centrum Leeuwarden B.V.
Coordinator of this site? Confirm its status
LeeuwardenNetherlandsRecruiting
Leids Universitair Medisch Centrum (LUMC)
Coordinator of this site? Confirm its status
LeidenNetherlandsRecruiting
Maastricht University Medical Center+ (MUMC+)
Coordinator of this site? Confirm its status
MaastrichtNetherlandsRecruiting
Sint Antonius Ziekenhuis Stichting
Coordinator of this site? Confirm its status
NieuwegeinNetherlandsRecruiting
Radboudumc
Coordinator of this site? Confirm its status
NijmegenNetherlandsRecruiting
Erasmus MC - Daniel
Coordinator of this site? Confirm its status
RotterdamNetherlandsRecruiting
UMCU
Coordinator of this site? Confirm its status
UtrechtNetherlandsRecruiting
Isala Klinieken Stichting
Coordinator of this site? Confirm its status
ZwolleNetherlandsRecruiting
Haukeland University Hospital
Coordinator of this site? Confirm its status
BergenNorwayRecruiting
Oslo University Hospital
Coordinator of this site? Confirm its status
OsloNorwayRecruiting
Stavanger Univ. Hosp.-Rogaland Hosp.
Coordinator of this site? Confirm its status
StavangerNorwayRecruiting
University Hospital of North Norway
Coordinator of this site? Confirm its status
TromsoNorwayRecruiting
St Olavs Hospital
Coordinator of this site? Confirm its status
TrondheimNorwayRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.